These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 824712)

  • 1. Mu heavy-chain disease--a defect in immunoglobulin assembly. Structural studies of the kappa chain.
    Frangione B; Franklin EC; Prelli F
    Scand J Immunol; 1976; 5(6-7):623-7. PubMed ID: 824712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunochemical study of serum in the diagnosis of mu-chain disease].
    Chernokhvostova EV; Batalova TN; Andreeva NE; Antipova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):42-8. PubMed ID: 404805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The defect in mu heavy chain disease protein GLI.
    Franklin EC; Frangione B; Prelli F
    J Immunol; 1976 Apr; 116(4):1194-5. PubMed ID: 815437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
    Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
    Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VKIIIb light chain sub-subgroup: restricted association with mu heavy chain in normal human serum.
    Moynihan JA; Looney RJ; Abraham GN
    Immunology; 1985 Feb; 54(2):207-13. PubMed ID: 3917972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical and biochemical study of a human Fcmu-like fragment (mu-chain disease).
    Lebreton JP; Ropartz C; Rousseaus J; Roussel P; Dautrevaus M; Biserte G
    Eur J Immunol; 1975 Mar; 5(3):179-84. PubMed ID: 824130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of immunoglobulin heavy and light chains in the absence of the VH domain.
    Levo Y; Recht B; Michaelsen T; Franklin EC; Frangione B
    J Immunol; 1977 Aug; 119(2):635-40. PubMed ID: 407302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and immunological properties of a mu chain disease protein.
    Mihaesco C; Mihaesco E; Miglierina R; Lamaziere J; Roy JP; Seligmann M
    Immunochemistry; 1976 Jan; 13(1):39-45. PubMed ID: 815173
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection and preparation of immunoglobulin (Ig) mu chain protein in sera of patients with heavy chain diseases (HCD).
    Wetter O; Drosdziok W; Müller B
    Klin Wochenschr; 1975 Sep; 53(18):885-6. PubMed ID: 809615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin structure, synthesis, secretion, and relation to neoplasms of B cells.
    Franklin EC; Buxbaum J
    Clin Haematol; 1977 Jun; 6(2):503-32. PubMed ID: 410572
    [No Abstract]   [Full Text] [Related]  

  • 12. [The primary structure of a monoclonic immunoglobulin-L-chain of subgroup IV of the kappa type (Bence-Jones protein Len.)].
    Schneider M; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1975 May; 356(5):507-57. PubMed ID: 50995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent immunoglobulin assembly in vitro: reactivity of light chain covalent dimers (L2) and blocked light chain monomers.
    Kazin AR; Beychok S
    Science; 1978 Feb; 199(4329):688-90. PubMed ID: 415360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological diagnosis of paraproteinemic hemoblastoses].
    Mokeeva RA; Zhuravlev VS; Shakhanina KL; Panurina RL; Morozova VT
    Gematol Transfuziol; 1984 Feb; 29(2):15-9. PubMed ID: 6423441
    [No Abstract]   [Full Text] [Related]  

  • 15. Bence Jones proteins: present diagnostic approaches.
    Ritzmann SE; Aguanno JJ; Finney MA; McCoy MT
    Lab Res Methods Biol Med; 1983; 8():147-71. PubMed ID: 6417425
    [No Abstract]   [Full Text] [Related]  

  • 16. Bence Jones proteins and light chains of immunoglobulins. XIV. Conformational dependency and molecular localization of the kappa (kappa) and lambda (lambda) antigenic determinants.
    Solomon A
    Scand J Immunol; 1976; 5(6-7):685-95. PubMed ID: 62385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid sequence of the first hypervariable region of 2 kappa and 2 lambda Bence Jones cryoglobulin.
    Meinke G; Spiegelberg HL
    Immunochemistry; 1976 Nov; 13(11):915-9. PubMed ID: 827495
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gamma-1 heavy chain disease with the demonstration of Bence-Jones proteins].
    Hauke G; Krawinkel U; Schiltz E; Metz B; Hollmann A; Peter HH
    Immun Infekt; 1991 Jun; 19(3):89-90. PubMed ID: 1916871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of heavy chain of 7S IgM half-molecule whose NH2-terminal sequence is identical with that of kappa light chain sequence in patients with Waldenstrom macroglobulinemia.
    Imoto M; Ishikawa K; Yamamoto K; Sinohara H; Irimajiri K; Kubo N; Sakurabayashi I; Horiuchi A; Akiyama T; Ohba Y; Furuta I
    Clin Chim Acta; 1999 Apr; 282(1-2):77-88. PubMed ID: 10340436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient.
    Hauke G; Schiltz E; Bross KJ; Hollmann A; Peter HH; Krawinkel U
    Scand J Immunol; 1992 Sep; 36(3):463-8. PubMed ID: 1519038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.